Here are three things to know:
1. One analyst rated the stock with a sell rating while three gave a hold rating.
2. The average one year price target issued by brokers who reported on the stock is $68.60.
3. NuVasive is a medical device company focused on creating minimally invasive spine products.
More device articles:
Medovex, AlfaMed, & more: 4 recent device company partnerships
Reprocessed medical devices market gaining traction — 4 observations
4 things to know about Intelligent Implant Systems
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
